Medicine
Emtricitabine 200 mg capsule
Emtricitabine 200 mg capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Emtricitabine
- Brand
- Sold under the generic name
- Strength
- 200 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 500 capsules, 30 capsules
- Manufacturers
- Aurobindo PharmaIndiaCiplaIndia
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF09 Emtricitabine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 August 2020
- Identifiers
- RxCUI 403875DailyMed set ID cdfb7868-3eba-46e1-a286-ca40760fd98d, a229c922-58eb-4795-9219-6cebb1779e35NDC 65862-301, 69097-642Application ANDA079188, ANDA091168
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 500 capsule in 1 bottle | 65862-301-05 | Aurobindo PharmaIndia | 15 March 2023 |
| 30 capsule in 1 bottle | 65862-301-30 | Aurobindo PharmaIndia | 15 March 2023 |
| 30 capsule in 1 bottle | 69097-642-02 | CiplaIndia | 31 August 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Emtricitabine 200 mg capsule.
Other strengths and forms of Emtricitabine
Clinical summary
Emtricitabine is a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. It is available as capsules and oral solution. MedsAcross supplies Emtricitabine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EmtricitabineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Emtriva prescribing information (Gilead Sciences) · U.S. National Library of Medicine, DailyMed
- Emtriva: European public assessment report (EPAR) · European Medicines Agency
Need Emtricitabine 200 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.